NATCO Pharma Limited

NSE:NATCOPHARM.NS

810.2 (INR) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 4,74813,71113,62610,6837,58610,31411,4058,9794,9254,3218,8465,5695,6053,7724,103-3053,5528,0225,6344,2764,8224,8574,9234,2305,5675,4355,3867,6785,6224,2674,2815,7786,428.64,152.12,977.13,9442,631.22,227.72,156.92,350.0331,842.72,090.61,904.82,171.2871,861.81,629.11,645.41,837.481,577.81,803.21,344.71,618.3641,293.11,266.5
Cost of Revenue 8281,7763,6633,4061,6222,1581,9602,5841,1541,0581,4774,1699309257911,5108311,9491,7892,2339151,1927601,7471,0509498731,2306581,1291,0941,1722,054.21,837.6926.9998921.5673.6698.4903.877630.5644.1656.51,053.163579.1578.6547890.456668.1665.8531.7914.798516.2478.3
Gross Profit 3,92011,9359,9637,2775,9648,1569,4456,3953,7713,2637,3691,4004,6752,8473,312-1,8152,7216,0733,8452,0433,9073,6654,1632,4834,5174,4864,5136,4484,9643,1383,1874,6064,374.42,314.52,050.22,9461,709.71,554.11,458.51,446.1561,212.21,446.51,248.31,118.1231,282.71,050.51,098.4947.024909.71,137.4813703.565776.9788.2
Gross Profit Ratio 0.8260.870.7310.6810.7860.7910.8280.7120.7660.7550.8330.2510.8340.7550.8075.9510.7660.7570.6820.4780.810.7550.8460.5870.8110.8250.8380.840.8830.7350.7440.7970.680.5570.6890.7470.650.6980.6760.6150.6580.6920.6550.5150.6890.6450.6680.5150.5770.6310.6050.4350.6010.622
Reseach & Development Expenses 00000008920001,6820001,4250001,5430001,8760001,279020009300161000000000142.852000146.336000000
General & Administrative Expenses 00000001,1580001,7720008490009040008730000000000000000000292.492000160.665000000
Selling & Marketing Expenses 00000006570003260002110009360008470000000000000000000261.604000148.207000000
SG&A 002,3562,8592,0642,3522,2731,8151,6561,2071,8972,0982,4751,0501,1331,0601,0141,2379521,8409781,0249321,7209339268871,2677887486311,086.7560604.2497.8615.5469.5430.4402.6290.569332.9336.9318.31,027.213297.6263.3258.9700.678244.73100000
Other Expenses 4,00211,93504203702941973,4143,1272,7273,8121,752302380170-642308257187-810308332210-9722334003592011145534-6361.5526.5275.14129.2121.380.2-394.208111.9101.7194.8-400.455171.8163.179.7-299.904198.3744.363.7-241.29494.7512.1
Operating Expenses 4,00211,9352,3562,8593,7254,0124,6003,4143,1272,7273,8121,7524,0172,4892,552-2,3902,1943,5962,4149812,8742,5412,4701,1752,6402,4832,5212,7952,2712,0791,9702,3302,209.71,902.11,632.72,1371,305.81,196.61,072.2741.664896.91,039.5967.6461.165979.6833.7769.4427.529659.7744.3613.4302.308597.4512.1
Operating Income -827,5857,6074,4182,6094,4385,0423,2718527413,900-4749603587605755272,4771,4311,0621,0331,1241,6931,3081,8772,0031,9923,6532,6931,0591,2172,2762,164.7412.4417.5809403.9357.5386.3704.492315.3407280.7656.958303.1216.8329519.495250393.1199.6401.257179.5276.1
Operating Income Ratio -0.0170.5530.5580.4140.3440.430.4420.3640.1730.1710.441-0.0850.1710.0950.185-1.8850.1480.3090.2540.2480.2140.2310.3440.3090.3370.3690.370.4760.4790.2480.2840.3940.3370.0990.140.2050.1540.160.1790.30.1710.1950.1470.3030.1630.1330.20.2830.1580.2180.1480.2480.1390.218
Total Other Income Expenses Net 1,719597429358-2,182-2,536-355-6561701673015325234015013227423015010525527014521617035033117171-939-5-7014.8-10.119.6-3217.8-55.91-399.52-124.5-40.5-50.4-338.69-79.5-80.4-19.9-303.202-70.6-120.117-214.33936.6-61.2
Income Before Tax 1,6378,1828,0364,7762,5634,3965,0003,2448147033,858-4969106989107078012,7071,5811,1671,2881,3941,8381,5242,0472,3532,3233,8242,7641,0721,2122,2062,479.8896.9660.6777497.3402.2385.7304.972190.8436.5409.9318.268382.7279.7309.1216.293318.4273216.6186.918216.1214.9
Income Before Tax Ratio 0.3450.5970.590.4470.3380.4260.4380.3610.1650.1630.436-0.0890.1620.1850.222-2.3180.2260.3370.2810.2730.2670.2870.3730.360.3680.4330.4310.4980.4920.2510.2830.3820.3860.2160.2220.1970.1890.1810.1790.130.1040.2090.2150.1470.2060.1720.1880.1180.2020.1510.1610.1150.1670.17
Income Tax Expense 3131,4171,351913436706797486191135654910647160177167668360235244217410320454537512827590228275442531.4234.7186.3141130.6110.4110.3-226.59854.2124.187.863.4108.237.1101.4132.064106.177.149.161.84850.458.3
Net Income 1,3306,7736,6853,8632,1273,6904,2032,7586235683,204-5058046517505306272,0241,2289411,0451,1901,4321,2081,5951,8251,8162,9992,1758489401,7671,951665475628369.3292.9280.7544.458143.4323.7334.6240.143298.8269.2217.8113.291225.9209.9170.7126.483170159.4
Net Income Ratio 0.280.4940.4910.3620.280.3580.3690.3070.1260.1310.362-0.0910.1430.1730.183-1.7380.1770.2520.2180.220.2170.2450.2910.2860.2870.3360.3370.3910.3870.1990.220.3060.3030.160.160.1590.140.1310.130.2320.0780.1550.1760.1110.160.1650.1320.0620.1430.1160.1270.0780.1310.126
EPS 7.4337.8137.3221.5611.8820.6123.2615.113.413.1117.56-2.774.413.574.112.913.4411.126.745.175.756.557.876.648.659.899.8416.2612.294.825.5910.111.183.792.743.862.131.811.72.990.871.962.021.321.871.721.390.621.441.351.10.691.181.13
EPS Diluted 7.4337.8137.3221.5611.8820.6123.2615.113.413.1117.55-2.764.43.574.112.913.4311.096.735.175.736.537.856.648.639.869.8216.2112.254.825.5810.0911.163.782.733.852.131.811.72.990.871.962.021.321.871.721.390.621.441.351.10.691.181.13
EBITDA 2,1518,6818,5295,3933,0514,8745,4773,6811,2671,1584,296-481,3201,0851,2681,0461,1333,0211,8981,5071,5951,6752,1231,7932,3172,6052,5354,0342,9791,2741,4012,4052,663.11,079.9772.5936664.1602.7574.6512.856397.7620.4571.7449.033551.9454.6481.8347.474457.6382.3307.6281.057315316.3
EBITDA Ratio 0.4530.6330.6260.5050.4020.4730.480.410.2570.2680.486-0.0090.2360.2880.309-3.430.3190.3770.3370.3520.3310.3450.4310.4240.4160.4790.4710.5250.530.2990.3270.4160.4140.260.2590.2370.2520.2710.2660.2180.2160.2970.30.2070.2960.2790.2930.1890.290.2120.2290.1740.2440.25